Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 2, 505-25

Pharmacotherapy of Post-Traumatic Stress Disorder

Affiliations
Review

Pharmacotherapy of Post-Traumatic Stress Disorder

Lakshmi N Ravindran et al. Curr Top Behav Neurosci.

Abstract

Post-traumatic stress disorder (PTSD) is a prevalent psychiatric disorder that may result in significant social and occupational debilitation unless symptoms are recognized and treated appropriately. Considerable research effort has been devoted over the last 20 years to developing effective pharmacological treatments for this illness. At this time, the bulk of the agents investigated include antidepressants, anticonvulsants, atypical antipsychotics, benzodiazepines, and antiadrenergic agents. Herein, we review the existing evidence base for these different classes of psychotropics in PTSD. Emphasis is placed on discussion of evidence stemming from randomized placebo-controlled clinical trials wherever possible. A brief description of novel agents that have shown initial promise for PTSD treatment is also provided.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback